Skip to content

Biosimilars and Biologics: Implementation and Monitoring in a Healthcare Setting

Approved Risk Evaluation and Mitigation Strategies (REMS)

Natalizumab REMS Strategy

Best Practices in Multiple Sclerosis Therapies

Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward

NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives

Best Practices in Formulary Management Unique Strategies for Biosimilar Adoption

ASHP Guidelines on Medication-Use Evaluation

How to Design a Medication Use Evaluation

(PDF Guideline)